AMANDA PERRODIN: Open Payments
NPI 1891073292 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,421 in 32 payments from 13 companies in 2025. Trend: 2023 $1,561 · 2024 $1,249 · 2025 $4,421
Consulting: $2,620Food & beverage: $1,632Education: $169
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $2,104 |
| E.R. Squibb & Sons, L.L.C. | 1 | $880 |
| Amgen Inc. | 9 | $505 |
| Janssen Scientific Affairs, LLC | 3 | $231 |
| Novartis Pharmaceuticals Corporation | 2 | $215 |
| GENZYME CORPORATION | 1 | $148 |
| SOBI, INC | 2 | $97 |
| SANOFI-AVENTIS U.S. LLC | 1 | $70 |
| Lilly USA, LLC | 1 | $67 |
| Ardelyx, Inc. | 2 | $46 |
Products named: TREMFYA, KRYSTEXXA, KEVZARA, COSENTYX, TALTZ, OTEZLA, IBSRELA, Bimzelx.
Industry payments across LA — which companies pay providers there.
